Key Takeaways J&J plans to separate its Orthopaedics franchise to form a standalone company named DePuy Synthes.The move aligns with J&J's strategy to emphasize high-growth MedTech markets.J&J expects the spin-off to lift MedTech revenue growth and margins.Along with its third-quarter earnings release on Oct. 14, Johnson & Johnson (JNJ) announced its intention to separate its Orthopaedics franchise within the MedTech segment.J&J plans to spin off the Orthopaedics franchise as a standalone company. The compa ...